Symptoms improved within first week: FDA approves new ADHD drug for children, adults
Simtriyo, the first approved ADHD drug to inhibit norepinephrine, dopamine and serotonin reuptake, improved symptoms within a week; US launch depends on controlled-substance classification, and it is not yet available in Israel
We haven't written up this one. Ynetnews Culture has the full story — the link below goes straight to it.
